2021 Q4 Form 10-Q Financial Statement
#000155837021015655 Filed on November 12, 2021
Income Statement
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $25.89M | $31.28M | $12.03M |
YoY Change | 139.54% | 160.02% | 11930.0% |
% of Gross Profit | |||
Research & Development | $58.77M | $56.89M | $29.97M |
YoY Change | 111.78% | 89.85% | 11425.38% |
% of Gross Profit | |||
Depreciation & Amortization | $0.00 | $11.11M | $0.00 |
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $84.66M | $99.28M | $42.00M |
YoY Change | 119.62% | 136.39% | 11899.71% |
Operating Profit | -$99.28M | -$42.00M | |
YoY Change | 136.39% | ||
Interest Expense | -$196.0K | $9.000K | -$557.0K |
YoY Change | -198.0% | -101.62% | |
% of Operating Profit | |||
Other Income/Expense, Net | $3.709M | $3.467M | $58.00K |
YoY Change | 50.77% | 5877.59% | -680.0% |
Pretax Income | -$81.15M | -$95.81M | -$42.50M |
YoY Change | 112.21% | 125.44% | 11385.95% |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$81.15M | -$95.81M | -$42.50M |
YoY Change | 112.21% | 125.44% | 11385.95% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.54 | ||
Diluted Earnings Per Share | -$420.1K | -$535.9K | -$257.7K |
COMMON SHARES | |||
Basic Shares Outstanding | 192.2M | 177.0M | |
Diluted Shares Outstanding | 178.8M |
Balance Sheet
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $244.0M | $233.8M | $19.60M |
YoY Change | -61.26% | 1093.02% | |
Cash & Equivalents | $244.0M | $233.8M | $19.71M |
Short-Term Investments | |||
Other Short-Term Assets | $47.12M | $22.92M | $4.800M |
YoY Change | 90.77% | 377.42% | |
Inventory | |||
Prepaid Expenses | |||
Receivables | $0.00 | $0.00 | $0.00 |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $291.1M | $256.7M | $24.40M |
YoY Change | -55.51% | 952.24% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $382.7M | $362.4M | $21.70M |
YoY Change | 276.49% | 1570.0% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $13.90M | $4.750M | $100.0K |
YoY Change | 4650.0% | ||
Total Long-Term Assets | $397.6M | $367.1M | $33.00M |
YoY Change | 252.6% | 1012.55% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $291.1M | $256.7M | $24.40M |
Total Long-Term Assets | $397.6M | $367.1M | $33.00M |
Total Assets | $688.8M | $623.9M | $57.40M |
YoY Change | -10.22% | 986.91% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $12.10M | $48.67M | $22.40M |
YoY Change | -62.82% | 117.26% | |
Accrued Expenses | $35.51M | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $63.50M |
YoY Change | -100.0% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $147.6M | $87.85M | $101.7M |
YoY Change | 333.19% | -13.62% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $1.000M |
YoY Change | -100.0% | -100.0% | |
Other Long-Term Liabilities | $1.578M | $3.529M | |
YoY Change | -98.44% | ||
Total Long-Term Liabilities | $1.578M | $3.529M | $1.000M |
YoY Change | 57.8% | 252.9% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $147.6M | $87.85M | $101.7M |
Total Long-Term Liabilities | $1.578M | $3.529M | $1.000M |
Total Liabilities | $149.2M | $91.38M | $102.7M |
YoY Change | 9.31% | -11.02% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$544.8M | -$463.7M | |
YoY Change | 305.24% | ||
Common Stock | $19.00K | $18.00K | |
YoY Change | 11.76% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $539.6M | $532.5M | -$45.34M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $688.8M | $623.9M | $57.40M |
YoY Change | -10.22% | 986.91% |
Cashflow Statement
Concept | 2021 Q4 | 2021 Q3 | 2020 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$81.15M | -$95.81M | -$42.50M |
YoY Change | 112.21% | 125.44% | 11385.95% |
Depreciation, Depletion And Amortization | $0.00 | $11.11M | $0.00 |
YoY Change | |||
Cash From Operating Activities | -$141.8M | -$74.87M | -$24.21M |
YoY Change | 393.56% | 209.21% | 34488.57% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$29.99M | -$79.93M | $0.00 |
YoY Change | -48.51% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $4.000K | ||
YoY Change | |||
Cash From Investing Activities | -$29.99M | -$79.93M | $4.000K |
YoY Change | -48.51% | -1998275.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 181.9M | 22.72M | 43.33M |
YoY Change | -73.9% | -47.56% | 10733.0% |
NET CHANGE | |||
Cash From Operating Activities | -141.8M | -74.87M | -24.21M |
Cash From Investing Activities | -29.99M | -79.93M | 4.000K |
Cash From Financing Activities | 181.9M | 22.72M | 43.33M |
Net Change In Cash | 10.18M | -132.1M | 19.12M |
YoY Change | -98.33% | -790.59% | 5695.15% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$141.8M | -$74.87M | -$24.21M |
Capital Expenditures | -$29.99M | -$79.93M | $0.00 |
Free Cash Flow | -$111.8M | $5.061M | -$24.21M |
YoY Change | -478.6% | -120.9% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2020Q4 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
4000000 | |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001759546 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
168000000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
182100000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
168007960 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-09-30 | ||
CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
182074899 | |
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-38821 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Lordstown Motors Corp. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
83-2533239 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2300 Hallock Young Road | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Lordstown | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
OH | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
44481 | ||
dei |
City Area Code
CityAreaCode
|
234 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
285-4001 | ||
dei |
Security12b Title
Security12bTitle
|
Class A Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
RIDE | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
192230903 | |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
233831000 | |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
629761000 | |
CY2020Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
21000 | |
CY2021Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
22916000 | |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
24663000 | |
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
256747000 | |
CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
654445000 | |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
362391000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
101663000 | |
CY2020Q4 | us-gaap |
Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
|
11111000 | |
CY2021Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
4750000 | |
CY2021Q3 | us-gaap |
Assets
Assets
|
623888000 | |
CY2020Q4 | us-gaap |
Assets
Assets
|
767219000 | |
CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
48666000 | |
CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
32536000 | |
CY2021Q3 | ride |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
39187000 | |
CY2020Q4 | ride |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
1538000 | |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
87853000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
34074000 | |
CY2020Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
1015000 | |
CY2021Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3529000 | |
CY2020Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
101392000 | |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
91382000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
136481000 | |
CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
182074899 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
168007960 | |
CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
18000 | |
CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
17000 | |
CY2021Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
996146000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
765162000 | |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-463658000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-134441000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
532506000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
630738000 | |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
623888000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
767219000 | |
CY2021Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
31281000 | |
CY2020Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
12033000 | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
79468000 | ||
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
20710000 | ||
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
56890000 | |
CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
29966000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
225246000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
43220000 | ||
CY2021Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11111000 | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11111000 | ||
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
99282000 | |
CY2020Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
41999000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
315825000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
63930000 | ||
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-99282000 | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-41999000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-315825000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-63930000 | ||
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3467000 | |
CY2020Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
58000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-13788000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2530000 | ||
CY2021Q3 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
9000 | |
CY2020Q3 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-557000 | |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
396000 | ||
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-921000 | ||
CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-95806000 | |
CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-42498000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-329217000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-62321000 | ||
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-95806000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42498000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-329217000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-62321000 | ||
CY2021Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.54 | |
CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.57 | |
CY2020Q4 | ride |
Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
|
2700000 | |
CY2020Q4 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
30700000 | |
CY2021Q1 | ride |
Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
|
600000 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.86 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.85 | ||
CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
178761000 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
73951000 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
176573000 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
73273000 | ||
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
599003000 | |
CY2021Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2724000 | |
CY2021Q3 | ride |
Stock Issued During Period Value Equity Line Of Credit
StockIssuedDuringPeriodValueEquityLineOfCredit
|
20000000 | |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6585000 | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-95806000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
532506000 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3549000 | |
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
708000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42498000 | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-45339000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
630738000 | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3822000 | ||
ride |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
194798000 | ||
ride |
Stock Issued During Period Value Equity Line Of Credit
StockIssuedDuringPeriodValueEquityLineOfCredit
|
20000000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
12365000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-329217000 | ||
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
532506000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8556000 | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6404000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2022000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-62321000 | ||
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-45339000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-329217000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-62321000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12365000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2022000 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
14918000 | ||
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11111000 | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
1015000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
2346000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-21000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
20000 | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
3001000 | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
4794000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
10929000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
20587000 | ||
ride |
Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
|
37649000 | ||
ride |
Increase Decrease In Accrued Liabilities And Due To Related Party
IncreaseDecreaseInAccruedLiabilitiesAndDueToRelatedParty
|
11267000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-246240000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-35605000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
255528000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
2396000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-255528000 | ||
CY2021Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
82000000.0 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
629761000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2159000 | |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
233831000 | |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19707000 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
55.8817 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q4 | ride |
Conversion Of Stock Shares Issued Per Share Tendered
ConversionOfStockSharesIssuedPerShareTendered
|
1 | |
CY2020Q4 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
7000000 | |
CY2020Q4 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
50000000 | |
CY2020Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2020Q4 | ride |
Stock Issued During Period Value Recapitalization
StockIssuedDuringPeriodValueRecapitalization
|
644600000 | |
CY2020Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
500000000 | |
CY2020Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
40000000 | |
CY2020Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
10.00 | |
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
1600000 | |
CY2020Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.00 | |
CY2020Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2396000 | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
82016000 | ||
ride |
Proceeds From Equity Based Line Of Credit
ProceedsFromEquityBasedLineOfCredit
|
20000000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3822000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6404000 | ||
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
44353000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
105838000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
50757000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-395930000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
17548000 | ||
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
233800000 | |
CY2020Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
100900000 | |
CY2020Q4 | ride |
Proceeds From Recapitalization
ProceedsFromRecapitalization
|
701500000 | |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-463700000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-329200000 | ||
us-gaap |
Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
|
true | ||
us-gaap |
Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
|
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Reclassifications</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> </span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The Company reclassified $2.3 million of gain on sale of fixed assets to <span style="-sec-ix-hidden:Hidden_cjZfu9V15k2EszSp3xhhKA;"><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:justify;">other</span></span> income during the nine months ended September 30, 2020 in order to consistently present its condensed consolidated financial statements. The reclassification did not impact net loss.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Immaterial Correction of Error </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The Company’s previously issued financial statements have been revised to reclassify certain expenses that were inappropriately presented within the consolidated statement of operations. This resulted in the reclassification of $2.7 million of research and development expenses to <span style="-sec-ix-hidden:Hidden_qUD_TI1SPEmyXtWPRbmMTA;"><span style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">selling</span></span><span style="white-space:pre-wrap;"> and administrative expenses for the nine months ended September 30, 2020. The error did not impact net loss.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;">The Company, in consultation with the Audit Committee of the Board of Directors, evaluated the effect of these adjustments on the Company’s consolidated financial statements under ASC 250, <i style="font-style:italic;">Accounting Changes </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">and Error Corrections </i>and Staff Accounting Bulletin No. 108, <i style="font-style:italic;">Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements</i> and determined it was not necessary to recall its consolidated condensed financial statements as the errors did not materially misstate those consolidated financial statements. The Company looked at both quantitative and qualitative characteristics of the required corrections.</p> | ||
CY2021Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
11100000 | |
us-gaap |
Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
|
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Warrants</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company accounts for its Public and Private Warrants as described in Note 3 in accordance with the guidance contained in ASC Topic 815-40-15-7D and 7F under which the Public Warrants and Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Public and Private Warrants as liabilities at their fair value and adjusts the Public and Private Warrants to fair value at each reporting period or at the time of settlement. Any change in fair value is recognized in the statement of operations as Other income/(expense).</span></p> | ||
CY2021Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-3344000 | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
14918000 | ||
CY2021Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
362391000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
101663000 | |
CY2021Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
362391000 | |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
101663000 | |
us-gaap |
Depreciation
Depreciation
|
0 | ||
us-gaap |
Depreciation
Depreciation
|
0 | ||
CY2019Q4 | us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
20000000.0 | |
CY2020Q2 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
2300000 | |
CY2020Q3 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
37800000 | |
CY2020Q4 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
4000000 | |
CY2021Q3 | ride |
Litigation Number Of Stockholder Demands For Records
LitigationNumberOfStockholderDemandsForRecords
|
8 | |
CY2021Q3 | ride |
Shares Authorized Common And Preferred
SharesAuthorizedCommonAndPreferred
|
312000000 | |
CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
12000000 | |
CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
182100000 | |
CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
168000000.0 | |
CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
178761000 | |
CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
73951000 | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
176573000 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
73273000 |